NCT03338556View on ClinicalTrials.gov

A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 6, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Viral Upper Respiratory Tract Infection
Interventions
DRUG

PrEP-001

OTHER

Placebo

Trial Locations (1)

E1 2AX

hVIVO Services Limited, QMB Innovation Centre, London

Sponsors

Collaborators (1)

Hvivo
All Listed Sponsors
collaborator

Hvivo

INDUSTRY

lead

Prep Biopharm Limited

INDUSTRY

NCT03338556 - A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16 | Biotech Hunter | Biotech Hunter